Santa Clara, CA, September 8, 2009 — Cell Biosciences, Inc. today announced that it has completed its acquisition of Alpha Innotech Corp. (OTC BB: APNO.OB). The stockholders of Alpha Innotech have approved the transaction, and all regulatory and other conditions have been satisfied. Pursuant to the merger agreement announced on September 8, 2009, former Alpha Innotech stockholders will receive $1.50 per share, or approximately $17.9 million in cash.
(Cell Biosciences has Changed Name to ProteinSimple.)
更多
Namocell在CRISPR中的最新应用---微管蛋白聚合抑制剂与癌症研究
厂商
2024.07.16
Namocell在无创产前筛查中的最新进展
厂商
2024.07.16
Namocell 助力NIH确立高效、安全的iPSC/hPSC单克隆技术
厂商
2024.07.16
Namocell分选单个植物原生质体用于单细胞测序
厂商
2024.07.16